WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013122413) ORAL FORMULATION COMPRISING LANSOPRAZOLE AND THE PREPARATION METHOD THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2013/122413 International Application No.: PCT/KR2013/001189
Publication Date: 22.08.2013 International Filing Date: 15.02.2013
IPC:
A61K 9/16 (2006.01) ,A61K 9/14 (2006.01) ,A61K 31/4439 (2006.01)
Applicants: DAEWOONG PHARMACEUTICAL CO., LTD.[KR/KR]; 223-23 Sangdaewon-dong Jungwon-gu, Seongnam-si, Gyeonggi-do 462-120, KR
Inventors: CHANG, Hee Chul; KR
KANG, Bok Ki; KR
KIM, Jung Soo; KR
Agent: Y.P.LEE, MOCK & PARTNERS; 12F Daelim Acrotel, 13 Eonju-ro 30-gil, Gangnam-gu, Seoul 135-971, KR
Priority Data:
10-2012-001546515.02.2012KR
Title (EN) ORAL FORMULATION COMPRISING LANSOPRAZOLE AND THE PREPARATION METHOD THEREOF
(FR) FORMULATION ORALE COMPRENANT DU LANSOPRAZOLE ET SON PROCÉDÉ DE PRÉPARATION
Abstract: front page image
(EN) An acid-unstable, insoluble lansoprazole-containing oral formulation, and a method of preparing the same are provided. The lansoprazole-containing oral formulation is resistant to activity loss caused by gastric juice, has improved dissolution characteristics, and thus ensures effective delivery of lansoprazole into the body through oral administration.
(FR) L'invention décrit une formulation orale contenant du lansoprazole insoluble, instable en milieu acide et son procédé de préparation. La formulation orale contenant du lansoprazole est résistante à la perte de l'activité provoquée par le suc gastrique, a des caractéristiques de dissolution améliorées, et, de ce fait, assure une administration efficace du lansoprazole, par voie orale, dans le corps.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)